![]() |
|
|
Vol. 286, Issue 1, 256-262, July 1998
Department of Pharmacology, In the present study, we examined denervation-induced changes in the
sensitivity of hypothalamic postsynaptic serotonin1A (5-HT1A) receptor function with respect to changes in the
dose-dependent elevation in plasma hormones [adrenocorticotropic
hormone (ACTH), corticosterone, prolactin, oxytocin, prolactin, renin
and vasopressin] by the 5-HT1A agonist
8-hydroxy-2-(dipropylamino)tetralin (8-OH-DPAT). Rats received
intracerebroventricular (i.c.v.) injections of the serotonin neurotoxin
5,7-dihydroxytryptamine (5,7-DHT) or vehicle (0.1% ascorbate in
saline) 3 weeks before challenge with increasing doses of 8-OH-DPAT (0, 10, 50 or 200 µg/kg s.c.). The effectiveness of 5,7-DHT-induced
destruction of serotonergic neurons was confirmed by a 93% reduction
in [3H]paroxetine-labeled 5-HT uptake sites in the
hypothalamus. No changes in basal levels of ACTH, corticosterone,
oxytocin, prolactin, renin and vasopressin were observed in rats that
received i.c.v. 5,7-DHT injections. The dose-response curves for
8-OH-DPAT-induced elevations of plasma corticosterone and prolactin
levels were shifted to the left in rats treated with 5,7-DHT, whereas
no significant difference in the ACTH dose-response curve was observed
between rats treated with vehicle and rats treated with 5,7-DHT. In
contrast, the maximal oxytocin response to 8-OH-DPAT was attenuated in
rats treated with 5,7-DHT. A 5,7-DHT-induced decline in the synthesis of oxytocin could explain this phenomenon. Although 8-OH-DPAT did not
increase plasma levels of renin or vasopressin in rats treated with
vehicle, 8-OH-DPAT produced an elevation (75%) in plasma renin
concentration but not in vasopressin levels in rats that received
i.c.v. injections of 5,7-DHT. No change was observed in
[3H]8-OH-DPAT labeled 5-HT1A receptors in the
hypothalamus. In summary, denervation of hypothalamic serotonergic
nerve terminals produces supersensitivity of some neuroendocrine
responses to 8-OH-DPAT independent of changes in the density of
hypothalamic 5-HT1A receptors.
0022-3565/98/2861-0256$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics
This article has been cited by other articles:
![]() |
D. N. D'Souza, Y. Zhang, F. Garcia, G. Battaglia, and L. D. Van de Kar Fluoxetine-induced changes in body weight and 5-HT1A receptor-mediated hormone secretion in rats on a tryptophan-deficient diet Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2004; 286(2): R390 - R397. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Ehlen, G. H. Grossman, and J. D. Glass In Vivo Resetting of the Hamster Circadian Clock by 5-HT7 Receptors in the Suprachiasmatic Nucleus J. Neurosci., July 15, 2001; 21(14): 5351 - 5357. [Abstract] [Full Text] [PDF] |
||||